We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$70.9B
AUM Growth
+$3.72B
(+5.5%)
Cap. Flow
+$541M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
4.9%
Holding
4,545
New
899
Increased
1,598
Reduced
1,287
Closed
504
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$395M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$321M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$318M |
| 4 |
ServiceNow
NOW
|
+$272M |
| 5 |
Schwab US REIT ETF
SCHH
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$547M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$447M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$377M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$299M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.53% |
| 2 | Financials | 13% |
| 3 | Industrials | 11.22% |
| 4 | Healthcare | 10.29% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Magic Empire Global Ltd
MEGL
$5.92M
| $20.9K | ﹤0.01% |
+17,771
| New | +$24.2K |
|
|
CASI
3902
DELISTED
CASI Pharmaceuticals
CASI
| $20.2K | ﹤0.01% |
23,787
-9,480
| -28% | -$12.3K |
|
|
CURX
3903
Curanex Pharmaceuticals
CURX
$7.39M
| $20.2K | ﹤0.01% |
+3,055
| New | +$33.6K |
|
|
IBO
3904
Impact BioMedical
IBO
$51.8M
| $20.1K | ﹤0.01% |
39,827
+8,327
| +26% | +$4.41K |
|
|
AMBR
3905
Amber International Holding Ltd
AMBR
$92M
| $19.9K | ﹤0.01% |
11,502
-1,111
| -9% | -$2.19K |
|
3906
PLAYSTUDIOS Inc
MYPS
$63.3M
| $19K | ﹤0.01% |
29,101
-123,965
| -81% | -$96.5K |
|
|
MDCX
3907
Medicus Pharma
MDCX
$17.2M
| $18.8K | ﹤0.01% |
+12,319
| New | +$26.4K |
|
3908
Bioceres Crop Solutions
BIOX
$28.1M
| $18.6K | ﹤0.01% |
+14,182
| New | +$22.7K |
|
|
APM
3909
DELISTED
Aptorum Group
APM
| $18.5K | ﹤0.01% |
+17,411
| New | +$25.6K |
|
|
PWCM
3910
PowerCompute Inc
PWCM
$1.26M
| $17.9K | ﹤0.01% |
1,612
-1,887
| -54% | -$45.1K |
|
|
WSTNR
3911
Westin Acquisition Corp Right
WSTNR
| $16.3K | ﹤0.01% |
+90,625
| New | +$16.3K |
|
|
NAMM
3912
Namib Minerals
NAMM
$84.3M
| $16.2K | ﹤0.01% |
+16,051
| New | +$29.6K |
|
|
BBLG
3913
Bone Biologics
BBLG
$1.73M
| $16.1K | ﹤0.01% |
+11,083
| New | +$22.1K |
|
3914
Educational Development Corp
EDUC
$11.7M
| $15.9K | ﹤0.01% |
+12,052
| New | +$16.5K |
|
3915
GEE Group
JOB
$27M
| $15.7K | ﹤0.01% |
80,700
-39,826
| -33% | -$7.74K |
|
3916
Phio Pharmaceuticals
PHIO
$13.7M
| $15.2K | ﹤0.01% |
+14,494
| New | +$23.2K |
|
3917
Femasys
FEMY
$24.8M
| $15.1K | ﹤0.01% |
+1,307
| New | +$19.8K |
|
3918
KALA BIO
KALA
$15.9M
| $15K | ﹤0.01% |
+538
| New | +$24.1K |
|
|
TRIB
3919
Trinity Biotech
TRIB
$8.62M
| $14.8K | ﹤0.01% |
622
-178
| -22% | -$5.25K |
|
3920
CN Energy Group
CNEY
$5.73M
| $14.6K | ﹤0.01% |
+23,833
| New | +$35.5K |
|
3921
BioCardia
BCDA
$15.3M
| $14K | ﹤0.01% |
+11,229
| New | +$15.3K |
|
3922
Atossa Therapeutics
ATOS
$25.3M
| $13.8K | ﹤0.01% |
+1,563
| New | +$19.8K |
|
|
HKPD
3923
Cellyan Biotechnology
HKPD
$19.8M
| $13.8K | ﹤0.01% |
+16,751
| New | +$18K |
|
3924
Huadi International Group
HUDI
$14.2M
| $13.7K | ﹤0.01% |
+12,205
| New | +$15.8K |
|
3925
AgEagle Aerial Systems
UAVS
$63.5M
| $13.3K | ﹤0.01% |
16,400
-4,489
| -21% | -$6.99K |
|
Similar funds
John Overdeck's Q4 2025 Portfolio in Review
As of Q4 2025, John Overdeck held 4,545 positions worth $70.9B, up 5.5% from $67.2B the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.
John Overdeck's Q4 2025 filing shows 899 new, 1,598 increased, 1,287 reduced and 504 closed positions. Its largest new stake was Vanguard Real Estate ETF: 3,573,400 shares worth $316M. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $547M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- John Overdeck's largest Q4 2025 buy was Vanguard Real Estate ETF: 3,573,400 shares worth $316M.
- John Overdeck added most to State Street Technology Select Sector SPDR ETF in Q4 2025, an estimated $395M increase.
- John Overdeck's biggest Q4 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $547M.
- John Overdeck fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2025, selling an estimated $240M.
- John Overdeck's ten largest holdings make up 4.9% of its $70.9B portfolio in Q4 2025.
- John Overdeck opened 899 new positions and closed 504 in Q4 2025.
- John Overdeck's portfolio value rose 5.5% quarter-over-quarter to $70.9B.
Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.